Leadership Moves
Written by: Aster Bancod, Executive Communications, CDO Magazine
Updated 7:00 AM EDT, September 16, 2026

Chitrang Davé, Immunic Chief Data and Digital Officer
Immunic, Inc., a late-stage biotechnology company developing novel oral therapies for neurologic diseases, has appointed Chitrang Davé Chief Data and Digital Officer (CDDO). In his role, Davé leads the company’s enterprise-wide data systems, analytics, AI, and digital strategy, with a focus on building a unified, commercial-ready data ecosystem.
Davé is establishing an organization spanning data science, data engineering, data management, and digital capabilities as Immunic transitions from late-stage clinical development toward commercial readiness. His responsibilities include supporting preparation of the data package for a potential New Drug Application (NDA) submission and commercialization of vidofludimus calcium (IMU-838) for multiple sclerosis (MS).
Prior to Immunic, Davé served as Head of Enterprise Data, AI & Advanced Analytics at Avidity Biosciences, where he defined and operationalized enterprise data strategy for a rapidly growing biotech preparing for commercial launch, translating AI strategy into a production portfolio spanning generative and agentic AI. Previously, he was Global Head of Enterprise Data & Analytics at Edwards Lifesciences, leading the company’s global data and analytics organization.
Davé brings more than 25 years of global leadership experience building and scaling data, advanced analytics, AI, governance, and digital capabilities across regulated life sciences environments. Earlier in his career, he spent 16 years at Medtronic in progressively senior data and analytics leadership roles, including Head of Data Products. He holds an MBA from Case Western Reserve University and a Bachelor of Engineering from M.S. University in India.
Highlighting his focus for the role, Davé noted in a LinkedIn post, “With pivotal trial readouts ahead and potential commercialization on the horizon, there is a unique opportunity to build a modern, commercial-ready data and digital foundation that supports Immunic’s next phase of growth.”